Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Angiology
Boston Scientific Announces Sale of TriVascular Endovascular Aortic Repair Program
April 18th, 2008
Boston Scientific Corporation (NYSE:BSX) announced the sale of Boston Scientific Santa Rosa Corp., formerly known as TriVascular, Inc., to TV2 Holding Company, a privately held company based in Santa Rosa, California. Boston Scientific Santa Rosa Corp. holds equipment and intellectual property related to the TriVascular endovascular aortic repair (EVAR) program. Terms of the sale include $30 million in cash paid at closing to Boston Scientific and a warrant allowing Boston Scientific to purchase a minority interest in TV2. Boston Scientific acquired TriVascular, which was founded to develop EVAR devices and procedures for treating abdominal aortic aneurysms, in April...
Source: Health Business Week (2008-04-18)
|
